For tests of cure (urethral, vaginal , and cervical films, and chocolate agar culture) patients were asked to attend 3 days after treatment and then once a week during the next 3 weeks. It was hoped to keep them under observation for a further 2 months, although it was not intended to examine the lower genitourinary tract during this time unless there was some indication that the disease might have recurred. Needless to say not all patients attended punctiliously and there was often a much longer interval between treatment and the follow-up examinations than had been planned.
Results
The results are outlined in Table II which shows the number of patients who defaulted immediately after treatment, those who had negative tests on the last occasion on which they were examined, treatment failures, and those who were cured and then re-infected. Of the thirteen patients shown as failures in Table II there was confidence that this assessment was correct in eight cases. Gonococci were isolated within 7 days of treatment in five of these patients, within 14 days in two (one of whom presented with acute salpingitis), and after 24 days in the last case.
It was much less certain that the other five cases were treatment failures, but there was insufficient evidence to indicate re-infection. One patient had negative test results after 5 days and positive results 3 days later. At this point the husband presented himself for treatment, but both husband and wife denied that there was any possibility that the wife had been re-infected. In the other four cases gonococci were found 12, 14, 17, and 21 days after treatment. All four were known to be very promiscuous and their claims that there had been no coitus since treatment were doubtful. These patients were re-treated with cephaloridine and it is probably significant that this treatment was successful in all four cases. In two cases, the dosage was similar to that given initially; in the other two cases the alternative treatment was given.
If there was lack of confidence regarding some of the cases classified as "failures", there was no such uncertainty regarding patients noted as reinfections, as in every case there was evidence to support this diagnosis. Of the seventeen patients re-infected, initial treatment had consisted of one injection of 2 g. cephaloridine in nine and two injections of 1 g. cephaloridine in the other eight. The intervals between the initial treatment and re-infection were as follows: 5 to 6 weeks-5; 7 to 9 weeks-3; 10 to 12 weeks-4; over 12 weeks-5.
These patients were re-treated with cephaloridine. Table III shows the number who had negative test results on the last occasion on which they attended the clinic. There was only one failure in this group-a patient who developed acute salpingitis after 2 g. cephaloridine in a single injection. Of these seventeen patients, four were re-infected a second time. It is interesting that they were all good attenders. In fact, three completed the surveillance period after treatment for the second infection, and the fourth had had three negative tests before contracting the disease for the third time. Re-treatment consisted of a single injection of 2 g. cephaloridine in one case-the other patients were given the divided dose. Treatment was successful in all four cases.
Results of Treatment
The results of initial treatment have been given in Table II . Table IV shows the results of therapy in the 217 infections in the 196 patients followed. There is no significant difference in the failure rate between the two dosage schedules (x2 =0 24; P >0 5). These results are very similar to those obtained with 2 g. cephaloridine in males by Marshall and Curtis (1967) , and show that this antibiotic provided effective treatment for gonorrhoea in females as well as in males. (The fact that the defaulters have been ignored should not affect this conclusion, as there is no reason to suppose that these patients responded less favourably to treatment than those who remained under observation.)
Adverse Reactions There were no adverse reactions in this series. Two patients have a history of penicillin sensitivity. Neither developed any reaction after cephaloridine therapy. However, Grieco (1967) has shown that there is cross-sensitivity between penicillin and cephaloridine, and acute allergic reactions have been observed in three Birmingham patients given cephaloridine for early syphilis because they were known to be allergic to penicillin.
Ten patients were pregnant when given cephaloridine. In 
